The chromatin remodelling component SMARCB1/INI1 influences the metastatic behavior of colorectal cancer through a gene signature mapping to chromosome 22

Journal of Translational Medicine

Vittorio Colantuoni⁵  Erminia Manfrin²  Roberto Vendraminelli⁴  Michele Ceccarelli⁵  Andrea Bonetti⁴  Alberto Talamini⁴  Filippo Greco⁴  Alberto Purgato⁴  Laura Pavan⁴  Paolo Piacentini⁴  Delfina Bifano¹  Michele Rocco¹  Laura Astati⁴  Carmelo Laudanna⁵  Arturo Di Blasi³  Lina Sabatino⁵  Caterina Zanella⁴  Andrea Remo⁴  Massimo Pancione⁵ 

[1] Department of Anatomic Pathology, AORN Santobono Pausilipon, Naples, Italy;Department of Pathology “G.B. Rossi” Hospital, University of Verona, Verona, Italy;Departments of Oncology and Pathology, Azienda Ospedaliera “G. Rummo”, Benevento, Italy;Department of Pathology, Surgery and Oncology “Mater Salutis” Hospital, ULSS21, Legnago, Verona, Italy;Department of Sciences and Technologies, University of Sannio, Via Port’Arsa, 11 82100 Benevento, Italy

关键词: Chromosome 22;    Colorectal cancer;    Integrase interactor 1;   

Others  :  824435
DOI  :  10.1186/1479-5876-11-297

 received in 2013-09-17, accepted in 2013-11-20,  发布年份 2013

【 授权许可】

   
2013 Pancione et al.; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Esteller M: Molecular origins of cancer: epigenetics in cancer. N Eng J of Med 2008, 358(11):1148-1196.
• [2]Dawson MA, Kouzarides T: Cancer epigenetics: from mechanism to therapy. Cell 2012, 150(1):12-27.
• [3]Biegel JA, Zhou JY, Rorke LB, Stenstrom C, Wainwright LM, Fogelgren B: Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors. Cancer Res 1999, 59(1):74-79.
• [4]Roberts CW, Biegel JA: The role of SMARCB1/INI1 in development of rhabdoid tumor. Cancer Biol Ther 2009, 8(5):412-416.
• [5]Reisman D, Glaros S, Thompson EA: The SWI/SNF complex and cancer. Oncogene 2009, 28(14):1653-1668.
• [6]Sevenet N, Lellouch-Tubiana A, Schofield D, Hoang-Xuan K, Gessler M, Birnbaum D, et al.: Spectrum of hSNF5/INI1 somatic mutations in human cancer and genotype-phenotype correlations. Human molecular genetics 1999, 8(13):2359-2368.
• [7]Hollmann TJ, Hornick JL: INI1-Deficient Tumors: Diagnostic Features and Molecular Genetics. Am J Surg Pathol 2011, 35(10):47-63.
• [8]Pancione M, Remo A, Colantuoni V: Genetic and epigenetic events generate multiple pathways in colorectal cancer progression. Patholog Res Int 2012, 2012:509348.
• [9]Remo A, Pancione M, Zanella C, Vendraminelli R: Molecular Pathology of Colorectal Carcinoma. A systematic review centred on the new role of Pathologist. Pathologica 2012, 104(6):432-441.
• [10]Pancione M, Remo A, Sabatino L, Zanella C, Votino C, Fucci A, et al.: Right-sided rhabdoid colorectal tumors might be related to the Serrated Pathway. Diagn Pathol 2013, 8:31. BioMed Central Full Text
• [11]Roberts CW, Leroux MM, Fleming MD, Orkin SH: Highly penetrant, rapid tumorigenesis through conditional inversion of the tumor suppressor gene Snf5. Cancer Cell 2002, 2(5):415-425.
• [12]Isakoff MS, Sansam CG, Tamayo P, Subramanian A, Evans JA, Fillmore CM, et al.: Inactivation of the Snf5 tumor suppressor stimulates cell cycle progression and cooperates with p53 loss in oncogenic transformation. Proc Natl Acad Sci U S A 2005, 102(49):17745-17750.
• [13]Remo A, Zanella C, Molinari E, Talamini A, Tollini F, Piacentini P, et al.: Rhabdoid carcinoma of the colon, a distinct entity with a very aggressive behaviour. A case report, associated with a polyposis coli and review of the literature. Int J Surg Pathol 2012, 20(2):185-190.
• [14]Loukola A, Eklin K, Laiho P, Salovaara R, Kristo P, Järvinen H, et al.: Microsatellite Marker Analysis in Screening for Hereditary Nonpolyposis Colorectal Cancer (HNPCC). Cancer Res 2001, 61(11):4545-4549.
• [15]Smith J, Deane N, Wu F, Merchant N, Zhang B, Jiang A, et al.: Experimentally derived metastasis gene expression profile predicts recurrence and death in patients with colon cancer. Gastroenterology 2010, 138(3):958-968.
• [16]Sheffer M, Bacolod MD, Zuk O, Giardina SF, Pincas H, Barany F, et al.: Association of survival and disease progression with chromosomal instability: a genomic exploration of colorectal cancer. Proc Natl Acad Sci U S A 2009, 106(17):7131-7136.
• [17]Wilson BG, Roberts CW: SWI/SNF nucleosome remodellers and cancer. Nat Rev Cancer 2011, 11(7):481-492.
• [18]Jones S, Li M, Parsons DW, Zhang X, Wesseling J, Kristel P, et al.: Somatic Mutations in the Chromatin Remodeling Gene ARID1A Occur in Several Tumor Types. Hum Mutat 2012, 33(1):100-103.
• [19]Kim MS, Je EM, Yoo NJ, Lee SH: Loss of ARID1A expression is uncommon in gastric, colorectal, and prostate cancers. APMIS 2012, 120(12):1020-1022.
• [20]Watanabe T, Semba S, Yokozaki H: Regulation of PTEN expression by the SWI/SNF chromatin-remodelling protein BRG1 in human colorectal carcinoma cells. Br J Cancer 2011, 104(1):146-154.
• [21]Network CGA: Comprehensive Molecular Characterization of Human Colon and Rectal Cancer. Nature 2012, 487(7407):330-337.
• [22]Papp G, Changchien YC, Péterfia B, Pecsenka L, Krausz T, Stricker TP, et al.: SMARCB1 protein and mRNA loss is not caused by promoter and histone hypermethylation in epitheliod sarcoma. Mod Pathol 2013, 26(3):393-403.
• [23]Vries RG, Bezrookove V, Zuijderduijn LM, Kia SK, Houweling A, Oruetxebarria , et al.: Cancer-associated mutations in chromatin remodeler hSNF5 promote chromosomal instability by compromising the mitotic checkpoint. Genes Dev 2005, 19(6):665-670.